Awarded at the LVI Congreso SEMICYUC 2021 the translational research group in the critically ill patient

Awarded at the LVI Congreso SEMICYUC 2021 the translational research group in the critically ill patient 1080 495 Guillem Cebrian

From 31 May to 4 June 2021, the XNUMXth National Congress of the Spanish Society of Intensive Care, Critical Care and Coronary Units was held in Barcelona (SEMICYUC).

The translational research group in the critical patient of I3PT has been recognized with both experimental research awards Dr. Juan Gómez Rubí to the best experimental papers presented at the congress.

Awards:

  • Lipopolysaccharide (LPS) treatment enhances the regenerative effect of exosomes derived from mesenchymal stem cells. Of the authors: Areny-Balagueró A, Camprubí-Rimblas M, Guillamat-Prats R, Blanch L, Closa D, Artigas A.

Second prize:

  • Effects of prolonged antithrombin or argatroban treatment for acute lung injury in rats. Of the authors: Camprubí-Rimblas M, Areny-Balagueró A, Campaña-Duel E, Morales-Quinteros L, Blanch L, Artigas A.
Guillem Cebrian

Graduate in Information and Documentation (UB) and Master in Management and Direction of Libraries and Information Services (UB). At I3PT I am in charge of the Knowledge Management Unit and I am in charge of collecting and disseminating its scientific production. I am passionate about new technologies, data management and open science.

All entries by: Guillem Cebrian

Leave a comment

Your email address will not be published.

Privacy preferences

When you visit our website, your browser may store information about specific services, usually in the form of cookies. Here you can change your privacy preferences. Please note that blocking certain types of cookies may affect your experience on our website and the services we offer.

Enable / disable Google Analytics tracking code
Enable / disable Google Fonts
Turn Google Maps on / off
Enable / disable embedded videos
This website uses cookies, mainly from third party services. You can edit your privacy preferences and / or accept the use of cookies.